The population genetics of multistage carcinogenesis

Proceedings of the Royal Society B: Biological Sciences

Volumn 270, Issue 1520, 2003, Pages 1183-1191

  Nunney, Leonard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Evolution; Genetic redundancy; Lineage selection; Mutation selection balance; Tumour suppressor

Indexed keywords

CANCER; POPULATION GENETICS;

ALLELE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL DIVISION; EMBRYO; FAMILIAL CANCER; GENE CONTROL; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; MATHEMATICAL MODEL; MUTATION RATE; POPULATION GENETICS; PRIORITY JOURNAL; RETINOBLASTOMA; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0038201472     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2003.2351     Document Type: Article

References (49)

1. Armitage, P. & Doll, R. 1954 The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer 8, 1-12.
2. Bardelli, A., Cahill, D. P., Lederer, G., Speicher, M. R., Kinzler, K. W., Vogelstein, B. & Lengauer, C. 2001 Carcinogen-specific induction of genetic instability. Proc. Natl Acad. Sci. USA 98, 5770-5775.
3. Boland, C. R. & Ricciardiello, L. 1999 How many mutations does it take to make a tumour? Proc. Natl Acad. Sci. USA 96, 14 675-14 677.
4. Cahill, D. P., Kinzler, K. W., Vogelstein, B. & Lengauer, C. 1999 Genetic instability and Darwinian selection in tumours. Trends Genet. 18, M57-M60.
5. Cairns, J. 1975 Mutation selection and the natural history of cancer. Nature 255, 197-200.
6. DePinho, R. A. 2000 The age of cancer. Nature 408, 248-254.
7. Dolle, M. E., Snyder, W. K., Gossen, J. A., Lohman, P. H. & Vijg, J. 2000 Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine. Proc. Natl Acad. Sci. USA 97, 8403-8408.
8. Frank, S. A. 1995 Mutual policing and repression of competition in the evolution of cooperative groups. Nature 377, 520-522.
9. Greaves, M. 2000 Cancer: the evolutionary legacy. Oxford University Press.
10. Gregori, G., Hanin, L., Luebeck, G., Moolgavkar, S. & Yakovlev, A. 2002 Testing goodness of fit for stochastic models of carcinogenesis. Math. Biosci. 175, 13-29.
11. Gutmann, D. H. & Collins, F. S. 1998 Neurofibromatosis type 1. In The genetic basis of human cancer (ed. B. Vogelstein & K. W. Kinzler), pp. 423-442. New York: McGraw-Hill.
12. Hanahan, D. & Weinberg, R. A. 2000 The hallmarks of cancer. Cell 100, 57-70.
13. Hethcote, H. W. & Knudson, A. G. 1978 Model for the incidence of embryonal cancers: application to retinoblastoma. Proc. Natl Acad. Sci. USA 75, 2453-2457.
14. Hoeijmakers, J. H. 2001 Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374.
15. Huttley, G. A., Jakobsen, I. B., Wilson, S. R. & Easteal, S. 2000 How important is DNA replication for mutagenesis? Mol. Biol. Evol. 17, 929-937.
16. Jones, P. & Laird, P. W. 1999 Cancer epigenetics comes of age. Nature Genet. 21, 163-167.
17. Knudson, A. G. 1971 Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820-823.
18. Knudson, A. G. & Strong, L. C. 1972 Mutation and cancer: neuroblastoma and pheochromocytoma. Am. J. Hum. Genet. 24, 514-532.
19. Linehan, W. M. & Klausner, R. D. 1998 Renal carcinoma. In The genetic basis of human cancer (ed. B. Vogelstein & K. W. Kinzler), pp. 455-473. New York: McGraw-Hill.
20. Loeb, L. A. 1991 Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075-3079.
21. MacCollin, M. & Gusella, J. 1998 Neurofibromatosis type 2. In The genetic basis of human cancer (ed. B. Vogelstein & K. W. Kinzler), pp. 443-453. New York: McGraw-Hill.
22. McKean, K. A. & Zuk, M. 1995 An evolutionary perspective on signaling in behavior and immunology. Naturwissenschaften 82, 509-516.
23. Malkin, D. 1998 The Li-Fraumeni syndrome. In The genetic basis of human cancer (ed. B. Vogelstein & K. W. Kinzler), pp. 393-407. New York: McGraw-Hill.
24. Maynard Smith, J. & Szathmáry, E. 1995 The major transitions in evolution. Oxford: Freeman.
25. Michod, R. E. 1996 Cooperation and conflict in the evolution of individuality. II. Conflict mediation. Proc. R. Soc. Lond. B 263, 813-822.
26. Michod, R. E. 1999a Darwinian dynamics, evolutionary transitions in fitness and individuality. Princeton University Press.
27. Michod, R. E. 1999b Individuality, mortality, and sex. In Levels of selection in evolution (ed. L. Keller), pp. 53-74. Princeton University Press.
28. Moolgavkar, S. H. 1986 Carcinogenesis modeling: from molecular biology to epidemiology. A. Rev. Public Hlth 7, 151-169.
29. Moolgavkar, S. H. & Luebeck, E. G. 1992 Multistage carcinogenesis: population-based model for colon cancer. J. Natl Cancer Inst. 84, 610-618.
30. Moolgavkar, S. H. & Venzon, D. J. 1979 Two-event models for carcinogenesis: incidence curves for childhood and adult tumors. Math. Biosci. 47, 55-65.
31. Newsham, I. F., Hadjistilianou, T. & Cavenee, W. K. 1998 Retinoblastoma. In The genetic basis of human cancer (ed. B. Vogelstein & K. W. Kinzler), pp. 363-392. New York: McGraw-Hill.
32. Nordling, C. O. 1953 A new theory on the cancer-inducing mechanism. Br. J. Cancer 7, 68-72.
33. Nowak, M. A., Boerlijst, M. C., Cooke, J. & Maynard Smith, J. 1997 Evolution of genetic redundancy. Nature 388, 167-171.
34. Nowell, P. C. 1976 The clonal evolution of tumor cell populations. Science 194, 23-28.
35. Nunney, L. 1991 The influence of age structure and fecundity on effective population size. Proc. R. Soc. Lond. B 246, 71-76.
36. Nunney, L. 1993 The influence of mating system and overlapping generations on effective population size. Evolution 47, 1329-1341.
37. Nunney, L. 1999a Lineage selection and the evolution of multistage carcinogenesis. Proc. R. Soc. Lond. B 266, 493-498. (DOI 10.1098/rspb.1999.0664.)
38. Nunney, L. 1999b Lineage selection: natural selection for long-term benefit. In Levels of selection in evolution (ed. L. Keller), pp. 238-252. Princeton University Press.
39. Orr-Weaver, T. L. & Weinberg, R. A. 1998 A checkpoint on the road to cancer. Nature 392, 223-224.
40. Phillips, P. C. & Johnson, N. A. 1998 The population genetics of synthetic lethals. Genetics 150, 449-458.
41. Ponder, B. A. J. 2001 Cancer genetics. Nature 411, 336-341.
42. Roze, D. & Michod, R. E. 2001 Mutation load, multi-level selection and the evolution of propagule size during the origin of multicellularity. Am. Nat. 158, 638-654.
43. Stewart, S. A. & Weinberg, R. A. 2000 Telomerase and human tumorigenesis. Semin. Cancer Biol. 10, 399-406.
44. Tautz, D. 1992 Redundancies, development and the flow of information. BioEssays 14, 263-266.
45. Tomlinson, I. & Bodmer, W. 1999 Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Med. 5, 11-12.
46. Tomlinson, I. P. M., Novell, M. R. & Bodmer, W. F. 1996 The mutation rate and cancer. Proc. Natl Acad. Sci. USA 93, 14 800-14 803.
47. Williams, G. C. 1957 Pleiotropy, natural selection and the evolution of senescence. Evolution 11, 398-411.
48. Wright, S. 1931 Evolution in Mendelian populations. Genetics 16, 97-159.
49. Yokota, J. 1994 Multistage carcinogenesis: involvement of tumour suppressor genes in the genesis and progression of human cancer. Bull. Inst. Pasteur 92, 256-259.